Cargando…

Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

BACKGROUND: In cases of EGFR‐tyrosine kinase inhibitor (TKI) failure, re‐biopsy may be useful to understand resistance mechanisms and guide further treatment decisions. However, performing re‐biopsy is challenging because of several hurdles. We assessed the feasibility of re‐biopsy in advanced non‐s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae‐Ok, Oh, In‐Jae, Kho, Bo Gun, Park, Ha Young, Chang, Jin Sun, Park, Cheol‐Kyu, Shin, Hong‐Joon, Lim, Jung‐Hwan, Kwon, Yong‐Soo, Kim, Yu‐Il, Lim, Sung‐Chul, Kim, Young‐Chul, Choi, Yoo‐Duk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026616/ https://www.ncbi.nlm.nih.gov/pubmed/29761660 http://dx.doi.org/10.1111/1759-7714.12762

Ejemplares similares

Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series
por: Shin, Hong-Joon, et al.
Publicado: (2019)

Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
por: Park, Ha Young, et al.
Publicado: (2016)

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
por: Park, Ha-Young, et al.
Publicado: (2019)

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report
por: Shin, Hong-Joon, et al.
Publicado: (2020)

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness
por: Kim, Tae-Ok, et al.
Publicado: (2021)

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study
por: Na, Young-Ok, et al.
Publicado: (2022)

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
por: Park, Seongho, et al.
Publicado: (2019)

Paradoxical pulmonary hemorrhage associated with hemocoagulase batroxobin in a patient with hemoptysis: A CARE-compliant case report
por: Kim, Tae-Ok, et al.
Publicado: (2021)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
por: Park, Hwa Kyung, et al.
Publicado: (2023)

Three cases of rigid bronchoscopic removal of carinal masses: Case report
por: Lee, Jae-Kyeong, et al.
Publicado: (2022)

Potentially fatal complications of systemic air embolism after computed tomography‐guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report
por: Oh, Hyung‐Joo, et al.
Publicado: (2020)

Life-threatening Mycobacterium intracellulare pleuritis in an immunocompetent host: Case reports
por: Kho, Bo-Gun, et al.
Publicado: (2021)

Usefulness of Mycobacterium tuberculosis-polymerase chain reaction with bronchial washing samples in predicting discontinuation of airborne infection isolation in patients hospitalized with suspected pulmonary tuberculosis
por: Kim, Tae-Ok, et al.
Publicado: (2022)

Hypersensitivity reactions to multiple anti-tuberculosis drugs
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Necrotizing tracheobronchitis causing airway obstruction complicated by pandemic 2009 H1N1 influenza: A case report
por: Chang, Jinsun, et al.
Publicado: (2020)

Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in Korea
por: Park, Cheol-Kyu, et al.
Publicado: (2016)

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
por: Park, Cheol-Kyu, et al.
Publicado: (2021)

Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer
por: Yoon, Seong-Hoon, et al.
Publicado: (2015)

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis
por: Lee, Jae-Kyeong, et al.
Publicado: (2022)

Efficacy of Afatinib in a Previously-Treated Patient with Non-Small Cell Lung Cancer Harboring HER2 Mutation: Case Report
por: Park, Cheol Kyu, et al.
Publicado: (2017)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer
por: Yoon, Joon‐Young, et al.
Publicado: (2019)

Review of Sarcoidosis in a Province of South Korea from 1996 to 2014
por: Kim, Min-Seok, et al.
Publicado: (2017)

Efficacy of an inpatient smoking cessation program at a single regional cancer center: A prospective observational study
por: Park, Ha-Young, et al.
Publicado: (2021)

Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery
por: Kho, Bo Gun, et al.
Publicado: (2020)

Predictors of Default from Treatment for Tuberculosis: a Single Center Case–Control Study in Korea
por: Park, Cheol-Kyu, et al.
Publicado: (2016)

Myasthenia gravis and myopathy after nivolumab treatment for non‐small cell lung carcinoma: A case report
por: Kim, Je‐Seong, et al.
Publicado: (2019)

Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Yu, Jeong Il, et al.
Publicado: (2012)

EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
por: Jung, Minkyu, et al.
Publicado: (2012)

Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment
por: Kim, Tae-Ok, et al.
Publicado: (2019)

Genomic Characterization and Comparison of Multi-Regional and Pooled Tumor Biopsy Specimens
por: Joung, Je-Gun, et al.
Publicado: (2016)

Feasibility of Endoscopic Resection for Sessile Nonampullary Duodenal Tumors: A Multicenter Retrospective Study
por: Park, Sung Min, et al.
Publicado: (2015)

Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literature
por: Kang, Hyun-Wook, et al.
Publicado: (2016)

Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment
por: Choi, Hayoung, et al.
Publicado: (2021)

Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary Adenocarcinoma
por: Lim, Ju Eun, et al.
Publicado: (2013)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Endovascular Stenting as a First Choice for the Palliation of Superior Vena Cava Syndrome
por: Kim, Yu-Il, et al.
Publicado: (2004)

Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis
por: Shin, Hong-Joon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gutlehenlfoaru9mrsip2lc2mf